As an antibacterial, dapsone inhibits bacterial synthesis of dihydrofolic acid, via competition with para-aminobenzoate for the active site of dihydropteroate synthase [REF].
When used for the treatment of skin conditions in which bacteria do not have a role, the mechanism or action of dapsone is not well understood.